Arcellx, Inc. (ACLX)
NASDAQ: ACLX · IEX Real-Time Price · USD
62.56
+0.32 (0.51%)
At close: Jul 19, 2024, 4:00 PM
62.62
+0.06 (0.10%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Arcellx Market Cap
Arcellx has a market cap or net worth of $3.35 billion as of July 22, 2024. Its market cap has increased by 116.18% in one year.
Market Cap
3.35B
Enterprise Value
2.86B
1-Year Change
116.18%
Ranking
Category
Stock Price
$62.56
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $3.35B, an increase of 565.23%. That is a compound annual growth rate of 116.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.35B | 23.87% |
| Dec 29, 2023 | 2.70B | 98.89% |
| Dec 30, 2022 | 1.36B | 170.02% |
| Feb 4, 2022 | 503.15M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 3.47B |
| Axonics | 3.46B |
| Arrowhead Pharmaceuticals | 3.45B |
| PROCEPT BioRobotics | 3.45B |
| IDEAYA Biosciences | 3.45B |
| HUTCHMED (China) | 3.31B |
| TG Therapeutics | 3.28B |
| Xenon Pharmaceuticals | 3.20B |